Abstract
Colon cancer is one of the common malignancies in the developed world irrespective of the sexes. The incidence of colon cancer is increasing leaps and bounds in the developing world also during the past few decades. Several risk factors including diet, environmental triggers, sedentary life style, and genetic susceptibility are known to predispose an individual for the development of colon cancer. Sex hormone estrogen plays a major role in various metabolic processes in the body, and deficiency in the levels of estrogen is reported to be a primary causative factor in the pathogenesis of many diseases including postmenopausal osteoporosis, cardiovascular disease, immune dysfunction, and many others. On the contrary, estrogens are also proven to exert a proproliferative effect in the reproductive organs, thereby establishing their role in the development of breast and endometrial cancers. Interestingly, hormone replacement therapy with estrogen is proven to reduce the risk of colorectal cancer (CRC) in postmenopausal women. Estrogen exerts its action by binding with nuclear receptors ERα and ERβ and also through binding with the membrane bound G-protein coupled estrogen receptor (GPER). Recent research has proven that the distribution of nuclear estrogen receptors alpha and beta in different organs and the preferential binding of estrogen to either of these receptors might be instrumental in determining the crucial switch between procarcinogenic and anticarcinogenic effects of estrogen. Reduced expression of the nuclear estrogen receptor beta in the colon is reported to enhance the risk of an individual for the development of CRC. This implicates the usefulness of estrogen receptor β expression as a reliable prognostic and diagnostic marker for CRC. In short, clinical endocrine therapies based on the estrogen-regulated expression of estrogen receptors, development of tissue selective estrogen receptor modulators, and phytoestrogen-based diets can all play a pivotal role in the prevention and therapy of colon cancer in the future. This chapter discusses the influence of estrogen and its constituent receptors in the development of colon cancers and as to how these can be exploited in the diagnosis, to monitor prognosis and to plan therapeutic regimes for the management of malignancies of the colon.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CIMP:
-
CpG island methylator phynotype
- CIN:
-
Chromosomal instability
- CRC:
-
colorectal cancer
- ER:
-
Estrogen receptor
- ERE:
-
Estrogen responsive elements
- FPA:
-
Familial adenomatous polyposis
- GPER:
-
G-protein coupled estrogen receptor
- HNPCC:
-
Hereditary nonpolyposis colorectal cancer
- SERD:
-
Selective estrogen receptor degrader
- SERM:
-
Selective estrogen receptor modulator
References
Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., et al. (2020). Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances, 38, 107322.
Alexander, D. D., Cushing, C. A., LowekaSceurman, B., & Roberts, M. A. (2009). Meta-analysis of animal fat or animal protein intake and colorectal cancer. The American Journal of Clinical Nutrition, 89, 1402–1409.
Amersi, F., Agustin, M., & Ko, C. Y. (2005). Colorectal cancer: Epidemiology, risk factors, and health services. Clinics in Colon and Rectal Surgery, 18(3), 133–140.
Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A. A., Black, H., et al. (2004). Effects of conjugated equine estrogen in postmenopausal women, with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA, 291(14), 1701–1712.
André, T., & Gramont, A. (2004). An overview of adjuvant systemic chemotherapy for colon cancer. Clinical Colorectal Cancer, 4(1), S22–S28.
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., et al. (2007). Nuclear receptor structure: Implications for function. Annual Review of Physiology, 69, 201–220.
Bassottia, G., & Battagliab, E. (2015). Physiology of the colon. Coloproctology. https://doi.org/10.1007/978-3-319-10154-5_7-1
Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M., & Clark, E. A. (2004). 17 beta estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cell. Blood, 2(104), 1404–1410.
Birkhauser, M. (1996). Treatment of pain in estrogen deficiency. Archives of Gynecology and Obstetrics, 259(Suppl 1), S74–S79.
Bjornstrom, L., & Sjoberg, M. (2005). Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology, 19, 833–842.
Bottner, M., Thelen, P., & Jarry, H. (2014). Estrogen receptor beta: Tissue distribution and the still largely enigmatic physiological function. The Journal of Steroid Biochemistry and Molecular Biology, 139, 245–251.
Burns, K. A., & Korach, K. S. (2012). Estrogen receptors and human disease: An update. Archives of Toxicology, 86, 1491–1504.
Bustos, V., Nolan, A. M., Nijhuis, A., Harvey, H., Parker, A., Poulsom, R., et al. (2017). GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget, 8, 84258–84275.
Bye, W. A., Nguyen, T. M., Parker, C. E., et al. (2017). Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews, 9, CD000279.
Card, J. W., & Zeldin, D. C. (2009). Hormonal influences on lung function and response to environmental agents: Lessons from animal models of respiratory disease. Proceedings of the American Thoracic Society, 6, 588–595.
Carothers, A. M., Hughes, S. A., Ortega, D., & Bertagnoli, M. M. (2002). 2-Methoxyestradiol induces p53 associated apoptosis of colorectal cancer cells. Cancer Letters, 187(1–2), 77–86.
Carreau, S., de Vienne, C., & Galeraud-Denis, I. (2008). Aromatase and estrogens in man reproduction: A review and latest advances. Adv Med Sci, 53, 139–144.
Casals-Casas, C., & Desvergne, B. (2011). Endocrine disruptors: From endocrine to metabolic disruption. Annual Review of Physiology, 73, 135–162.
Chang, E. C., Frasor, J., Komm, B., et al. (2006). Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology, 147, 4831–4842.
Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, A. F., Ascensao, J., Rodabough, R. J., et al. (2004). Estrogen plus progestin and colorectal cancer in postmenopausal women. The New England Journal of Medicine, 350(10), 991–1004.
Cianchi, F., Trallori, G., Mallardi, B., et al. (2015). Survival after laparoscopic and open surgery for colon cancer: A comparative, single-institution study. BMC Surgery, 15, 33.
Clendenen, T. V., Koenig, K. I., Shore, R. E., Levitz, M., Arslan, A. A., & Zeleniuch-Jacquotte, A. (2009). Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 18(1), 275–281.
Cui, J., Shen, Y., & Li, R. (2013). Estrogen synthesis and signaling pathways during aging: From periphery to brain. Trends in Molecular Medicine, 19(3), 197–209.
Cvoro, A., Tatomer, D., Tee, M.-K., Zogovic, T., et al. (2008). Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. Journal of Immunology, 180, 630–636.
Deyhle, P., Largiader, F., Jenny, S., et al. (1973). A method for endoscopic electroresection of sessile colonic polyps. Endoscopy, 5, 38–40.
Dray, X., Ruault, M. B., Sapinhi, D., Bouvier, A. M. B., & Faivre, J. (2003). Influence of dietary factors on colorectal cancer survival. Gut, 52(6), 868–873.
Edvardsson, K., Strom, A., Jonsson, P., Gustafsson, J., & Williams, C. (2011). Estrogen receptor β induces anti-inflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology, 25, 969–979.
Ewing, I., Hurley, J. J., Josephides, E., & Millar, A. (2014). The molecular genetics of colorectal cancer. Frontline Gastroenterology, 5(1), 26–30.
Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 451–457.
Fernandez, F., La Vecchia, C., Balducci, A., et al. (2001). Oral contraceptives and colorectal cancer risk : A meta analysis. British Journal of Cancer, 84(5), 722–727.
Frasor, J., Danes, J. M., Komm, B., et al. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology, 144, 4562–4574.
Gill, S., Thomas, R. R., & Goldberg, R. M. (2003). Review article: Colorectal cancer chemotherapy. Alimentary Pharmacology & Therapeutics, 18(7), 683–692.
Gilligan, L. C., Gondal, A., Tang, V., Hussain, M. T., Arvaniti, A., Hewitt, A. M., & Foster, P. A. (2017). Estronesulfate transport and steroid sulfatase activity in colorectal cancer: Implications for hormone replacement therapy. Frontiers in Pharmacology, 8, 103.
Granados-Romero, J. J., Valderrama-Treviño, A. I., Contreras-Flores, E. H., et al. (2017). Colorectal cancer: A review. International Journal of Research in Medical Sciences, 5(11), 4667–4676.
Gronemeyer, H., Gustafsson, J. A., & Laudet, V. (2004). Principles for modulation of the nuclear receptor superfamily. Nature Reviews Drug Discovery, 3, 950–964.
Gruber, C. J., Tschugguel, W., Schneeberger, C., et al. (2002). Production and actions of estrogens. The New England Journal of Medicine, 346, 340–352.
Guan, X., Zhao, Z., Yang, M., et al. (2017). Whether partial colectomy is oncologically safe for patients with transverse colon cancer: A large population-based study. Oncotarget, 8(54), 93236–93244.
Gunter, M. J., Hoover, D. R., Yu, H., TE Wassertheil-Smoller, R., Manson, J. E., et al. (2008). Insulin, insulin-like growth factor-I, endogenous estradiol and risk of colorectal cancer in postmenopausal women. Cancer Research, 68(1), 329–337.
Haas, M. J., Raheja, P., Jaimungal, S., et al. (2012). Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radical Biology & Medicine, 52, 2161–2167.
Haggar, F. A., & Boushey, R. P. (2009). Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clinics in Colon and Rectal Surgery, 22(4), 191–197.
Hamilton, E. P., Patel, M. R., Armstrong, A. C., et al. (2018). A first-in-human study of the new Oral selective Estrogen receptor degrader AZD9496 for ER(+)/HER2(−) advance breast Cancer. Clinical Cancer Research, 24, 3510–3518.
Harshman, M. R. (2007). Diet and colorectal cancer. Canadian Family Physician, 53(11), 1913–1920.
Heldring, N., Pike, A., Andersson, S., et al. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87, 905–931.
Henrikson, N. B., Webber, E. M., Katrina, A., et al. (2015). Family history and the natural history of colorectal cancer: Systematic review. Genetics in Medicine, 17(9), 702–712.
Hsu, H. H., Cheng, S. F., Wu, C. C., et al. (2006). Apoptotic effects of overexpressed estrogen receptor beta on LOVO colon cancer cell is mediated by p 53 signallings in a ligand-dependent manner. The Chinese Journal of Physiology, 49(2), 110–116.
Huang, P., Chandra, V., & Rastinejad, F. (2010). Structural overview of the nuclear receptor superfamily: Insights into physiology and therapeutics. Annual Review of Physiology, 72, 247–272.
Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., et al. (1992). Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America, 89, 4658–4662.
Inoue, T., Miki, Y., Abe, K., et al. (2012). Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin. Molecular and Cellular Endocrinology, 362, 19–28.
Issa, J. P. (2008). Colon cancer: Its CIN or CIMP. Clinical Cancer Research, 14(19), 5939–5940.
Jensen, E. V., Jacobson, H. E., Flesher, J. W., et al. (1966). Estrogen receptors in target tissues. In T. Nakao, G. Pincus, & J. Tait (Eds.), Steroid dynamics (pp. 133–157). New York, NY: Academic Press.
Jia, M., Dahlman-Wright, K., & Gustafsson, J. A. (2015). Estrogen receptor alpha and beta in health and disease. Best Practice and Research: Clinical Endocrinology and Metabolism, 29, 557–568.
Jin, P., Lu, X. J., Sheng, J. Q., Fu, L., et al. (2010). Estrogen stimulates the expression of mismatch repair genes MLH 1 in colonic epithelial cells. Cancer Prevention Research (Philadelphia, PA), 3(8), 910–916.
Jonsson, P., Katchy, A., & Williams, C. (2014). Support of a bi-faceted role of estrogen receptor beta (ERbeta) in ERalpha-positive breast cancer cells. Endocrine-Related Cancer, 21, 143–160.
Jordan, V. C. (2001). Selective estrogen receptor modulation: A personal perspective. Cancer Research, 61, 5683–5687.
Jung, J. (2019). G protein coupled estrogen receptor in cancer progression. Toxicological Research, 35, 209–214.
Kasprzak, A., & Adamek, A. (2019). Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. International Journal of Molecular Sciences, 20(19), 4915.
Kato, S., Endoh, H., Masuhiro, Y., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491–1494.
Kim, E. R., & Chang, D. K. (2014). Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World Journal of Gastroenterology, 20(29), 9872–9881.
Klotz, D. M., Hewitt, S. C., Ciana, P., Raviscioni, M., et al. (2002). Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)- induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. The Journal of Biological Chemistry, 277, 8531–8537.
Kotov, A., Falany, J. L., Wang, J., et al. (1999). Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. The Journal of Steroid Biochemistry and Molecular Biology, 68, 137–144.
Koushik, A., Hunter, D. J., Spiegelman, D., et al. (2007). Fruits, vegetables and colon cancer risk in a pooled analysis of 14 cohort studies. Journal of the National Cancer Institute, 99, 1471–1483.
Kovats, S., & Carreas, E. (2008). Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cellular Immunology, 252, 81–90.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., et al. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America, 93, 5925–5930.
Kuipers, E. J., Grady, W. M., Lieberman, D., et al. (2015). Colorectal cancer. Nature Reviews. Disease Primers, 1, 15065.
Lechner, D., Kállay, E., & Cross, H. S. (2005). Phytoestrogens and colorectal cancer prevention. Vitamins & Hormones, 70, 169–198.
Leung, Y. K., Mak, P., Hassan, S., et al. (2006). Estrogen receptor (ER)-beta isoforms: A key to understanding ER-beta signaling. Proceedings of the National Academy of Sciences of the United States of America, 103, 13162–13167.
Levin, E. R. (2009). Plasma membrane estrogen receptors. Trends in Endocrinology and Metabolism, 20, 477–482.
Liao, T. L., Tzeng, C. R., Yu, C. L., et al. (2015). Estrogen receptor-beta in mitochondria: Implications for mitochondrial bioenergetics and tumorigenesis. Annals of the New York Academy of Sciences, 1350, 52–60.
Lin, J. H., & Giovannucci, E. (2010). Sex hormones and colorectal cancer: What have we learned so far? Journal of the National Cancer Institute, 102(23), 1746–1747.
Lombardi, G., Zarrilli, S., Colao, A., et al. (2001). Estrogens and health in males. Molecular and Cellular Endocrinology, 178, 51–55.
Lynch, P. M. (2017). History of hereditary non polyposis colorectal cancer or “Lynch syndrome”. Revista Médica Clínica Las Condes, 28(4), 500–511.
Maggiolini, M., Vivacqua, A., Fasanella, G., et al. (2004). The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. The Journal of Biological Chemistry, 279, 27008–27016.
Martin, M. B., Franke, T. F., & Stoica, G. E. (2000). A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology, 141, 4503–4511.
Mastalier, B., Tihon, C., Ghiţă, B., et al. (2012). Surgical treatment of colon cancer: Colentina surgical clinic experience. Journal of Medicine and Life, 5(3), 348–353.
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Reviews, 34(3), 309–338.
Mazaira, G. I., Zgajnar, N. R., Lotufo, C. M., et al. (2018). The nuclear receptor field: A historical overview and future challenges. Nuclear Receptor Research, 5, 101320.
Menon, R., Watson, S. E., Thomas, L. N., Alfred, C. D., et al. (2013). Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Applied and Environmental Microbiology, 79, 5763.
Murphy, N., Xu, L., Zervoudakis, A., TE Xue, X., et al. (2017). Reproductive and menstrual factors and colorectal cancer incidence in the Womens Health Initiative Observational Study. British Journal of Cancer, 116, 117–125.
Nardone, A., Weir, H., Delpuech, O., et al. (2019). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. British Journal of Cancer, 120, 331–339.
Neubig, R. R., Spedding, M., Kenakin, T., et al. (2003). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacological Reviews, 55, 597–606.
Nilsson, S., & Gustafsson, J. A. (2011). Estrogen receptors: Therapies targeted to receptor subtypes. Clinical Pharmacology and Therapeutics, 89, 44–55.
Nilsson, S., Koehler, K. F., & Gustafsson, J. A. (2011). Development of subtype-selective oestrogen receptor-based therapeutics. Nature Reviews Drug Discovery, 10, 778–792.
Pancione, M., Remo, A., & Colantuoni, V. (2012). Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Pathology Research International, 2012, 509348.
Paterni, I., Granchi, C., Katzenellenbogen, J. A., et al. (2014). Estrogen receptors alpha (ERalpha) and beta (ERbeta): Subtype-selective ligands and clinical potential. Steroids, 90, 13–29.
Patrone, C., Ma, Z. Q., Pollio, G., et al. (1996). Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Molecular Endocrinology, 10, 499–507.
Pedram, A., Razandi, M., & Levin, E. R. (2006). Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology, 20, 1996–2009.
Pietras, R. J., & Marquez-Garban, D. C. (2007). Membrane-associated estrogen receptor signaling pathways in human cancers. Clinical Cancer Research, 13, 4672–4676.
Pinheiro, M., Ahlquist, T., Danielsen, S. A., et al. (2010). Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin. BMC Cancer, 10, 587.
Potter, J. D. (1996). Nutrition and colorectal cancer. Cancer Causes and Control, 7, 127–146.
Power, R. F., Mani, S. K., Codina, J., et al. (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636–1639.
Prossnitz, E. R., & Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nature Reviews Endocrinology, 7, 715–726.
Rawla, P., Sunkara, T., & Barsouk. (2019). Epidemiology of colorectal cancer:Incidence, mortality, survival, and risk factors. Przegla̜d Gastroenterologiczny, 14(2), 89–103.
Rawluszko-Wieczorek, A. A., Marczak, L., et al. (2017). Significance of intratissue estrogen concentration coupled with estrogen receptor levels in colorectal cancer prognosis. Oncotarget, 8(70), 115546–115560.
Revankar, C. M., Cimino, D. F., Sklar, L. A., et al. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (New York, NY), 307, 1625–1630.
Richardson, T. E., Yu, A. E., Wen, Y., et al. (2012). Estrogen prevents oxidative damage to the mitochondria in Friedreich’s ataxia skin fibroblasts. PLoS One, 7, e34600.
Riihimäki, M., Hemminki, A., Sundquist, J., & Hemminki, K. (2016). Patterns of metastasis in colon and rectal cancer. Scientific Reports, 6, 29765.
Rosenbaum, D. M., Rasmussen, S. G., & Kobilka, B. K. (2009). The structure and function of G-protein-coupled receptors. Nature, 459, 356–363.
Sameer, A. S. (2013). Colorectal cancer: Molecular mutations and polymorphisms. Frontiers in Oncology, 3, 114.
Santen, R. J., Brodie, H., Simpson, E. R., et al. (2009). History of aromatase: Saga of an important biological mediator and therapeutic target. Endocrine Reviews, 30, 343–375.
Santolla, M. F., Lappano, R., De Marco, P., Pupo, M., Vivacquo, A., Sisci, D., et al. (2012). G-Protein Coupled Estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17 beta estradiol in cancer cells and cancer associated fibroblasts. Journal of Biological Chemistry, 287, 43234–43245.
Sarkar, S., Horn, G., & Moulton, K. (2013). Cancer development, progression, and therapy: An epigenetic overview. International Journal of Molecular Sciences, 14(10), 21087–21113.
Schreihofer, D. A., Resnick, E. M., Lin, V. Y., et al. (2001). Ligand-independent activation of pituitary ER: Dependence on PKA stimulated pathways. Endocrinology, 142, 3361–3368.
Sladek, F. M. (2003). Nuclear receptors as drug targets: New developments in coregulators, orphan receptors and major therapeutic areas. Expert Opinion on Therapeutic Targets, 7, 679–684.
Slattery, M. I., Sweeny, C., Murtaugh, M., Ma, M., Wolff, R. K., Potter, J. D., et al. (2005). Associations between ER alpha, ER beta and AR genotypes and colon and rectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 14(12), 2936–2942.
Tanaka, T. (2009). Colorectal carcinogenesis: Review of human and experimental animal studies. Journal of Carcinogenesis, 8, 5.
Tariq, K., & Ghias, K. (2016). Colorectal cancer carcinogenesis: A review of mechanisms. Cancer Biology & Medicine, 13(1), 120–135.
Terzic, J., Grivennikov, S., Karin, E., & Karin, M. (2010). Inflammation and colon cancer. Review Gastroenterology, 138(6), 2101–2114.e5.
Thompson, C. A., Forest, A. D., & Battle, M. A. (2018). Patterning the gastrointestinal epithelium to confer regional-specific functions. Developmental Biology, 435(2), 97–108.
Topi, G., Ehmstrom, R., Jirstrom, K., Palmquist, J., Lydrup, M., & Sjolander, A. (2017). Association of the estrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer. European Journal of Cancer, 83, 279–289.
Umar, S. (2010). Intestinal stem cells. Current Gastroenterology Reports, 12(5), 340–348.
Wettschureck, N., & Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiological Reviews, 85, 1159–1204.
Xie, Y. H., Chen, Y. X., & Fang, J. Y. (2020). Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy, 5(1), 22.
Yager, J. D., & Chen, J. Q. (2007). Mitochondrial estrogen receptors--new insights into specific functions. Trends in Endocrinology and Metabolism, 18, 89–91.
Ye, S., Cheng, Y., Zhang, L., Wang, X., et al. (2019). Prognostic value of estrogen receptor αand progesterone receptor in curatively resected colorectal cancer: A retrospective analysis with independent validations. BMC Cancer, 19, 933.
Yue, W., Wang, J. P., Li, Y., et al. (2010). Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. International Journal of Cancer, 127, 1748–1757.
Zauber, A. G., Winawer, S. J., O'Brien, M. J., et al. (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. The New England Journal of Medicine, 366(8), 687–696.
Zhu, G., Huang, Y., Wu, C., Wei, D., & Shi, Y. (2016). Activation of G Protein-Coupled Estrogen receptor inhibits the migration of human non small cell lung cancer cells via IKK beta/NF-kappa B signals. DNA and Cell Biology, 35, 434–442.
Acknowledgments
The authors thank the University Grants Commission (UGC), Government of India, for the financial assistance provided to the Department of Microbiology and Biotechnology, Bangalore University, Bangalore, in the form of Special Assistance Programme (SAP)-DRS II which provided support for extensive literature survey and procurement of stationery material and to incur expenditure toward printing and photocopying charges for writing this chapter. Dr. SK acknowledges the financial assistance provided by UGC, GOI, in the form of postdoctoral fellowship (Dr. D.S. Kothari-PDF).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sumalatha, K.R., Soumyakrishnan, S., Sreepriya, M. (2022). The Triad of Estrogen, Estrogen Receptors, and Colon Cancer. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-72702-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-72701-7
Online ISBN: 978-3-030-72702-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)